(1.33%) 5 131.77 points
(1.17%) 38 672 points
(2.10%) 16 173 points
(-1.18%) $78.02
(5.85%) $2.15
(-0.06%) $2 308.30
(-0.62%) $26.66
(0.22%) $964.75
(-0.38%) $0.929
(-1.25%) $10.85
(-0.14%) $0.797
(0.37%) $91.46
5 days till quarter result
(bmo 2024-05-08)
Expected move: +/- 6.06%
-3.33% $ 1.450
Live Chart Being Loaded With Signals
Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vaccines and drugs, such as virus like particles and antigens, monoclonal antibodies, bi/tri-specific antibodies, fab antibody fragments, Fc-fusion proteins, biosimilars and/or biobetters, and other therapeutic enzymes and proteins...
Stats | |
---|---|
Dzisiejszy wolumen | 12 298.00 |
Średni wolumen | 22 179.00 |
Kapitalizacja rynkowa | 42.39M |
EPS | $0 ( 2024-03-28 ) |
Następna data zysków | ( $-0.0700 ) 2024-05-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -6.04 |
ATR14 | $0.0250 (1.75%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-11 | Lucy Patrick K. | Buy | 13 125 | Stock Option |
2024-04-11 | Tarnok Michael P. | Sell | 13 125 | Stock Option |
2024-04-11 | Hazelton Joseph P | Buy | 20 000 | Stock Option |
2024-03-13 | Hazelton Joseph P | Buy | 41 720 | Common Stock |
2024-03-13 | Emalfarb Mark A | Buy | 124 454 | Common Stock |
INSIDER POWER |
---|
81.62 |
Last 99 transactions |
Buy: 3 507 936 | Sell: 1 014 811 |
Dyadic International Inc Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
RMRM | 0.973 |
TLGT | 0.916 |
APOP | 0.914 |
FCNCA | 0.9 |
SVAC | 0.897 |
TDAC | 0.895 |
XERS | 0.885 |
AQST | 0.885 |
BRKS | 0.885 |
BLRX | 0.884 |
10 Najbardziej negatywne korelacje | |
---|---|
MMAC | -0.936 |
NETE | -0.919 |
AMRB | -0.908 |
AEY | -0.897 |
BOCH | -0.893 |
TRUP | -0.89 |
PBHC | -0.887 |
EM | -0.884 |
MTP | -0.882 |
OBT | -0.878 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Dyadic International Inc Finanse
Annual | 2023 |
Przychody: | $2.90M |
Zysk brutto: | $922 957 (31.84 %) |
EPS: | $-0.240 |
FY | 2023 |
Przychody: | $2.90M |
Zysk brutto: | $922 957 (31.84 %) |
EPS: | $-0.240 |
FY | 2022 |
Przychody: | $2.93M |
Zysk brutto: | $807 110 (27.54 %) |
EPS: | $-0.330 |
FY | 2021 |
Przychody: | $2.40M |
Zysk brutto: | $459 393 (19.11 %) |
EPS: | $-0.470 |
Financial Reports:
No articles found.
Dyadic International Inc
Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vaccines and drugs, such as virus like particles and antigens, monoclonal antibodies, bi/tri-specific antibodies, fab antibody fragments, Fc-fusion proteins, biosimilars and/or biobetters, and other therapeutic enzymes and proteins. It offers DYAI-100, SARS-CoV-2-RBD antigen vaccine candidate towards a first-in-human Phase 1 clinical trial, is to validate to serve as proof of concept for the development of next generation multivariant COVID-19 vaccine candidates. The company has a research and development agreement with VTT Technical Research Centre of Finland, Ltd.; strategic research services agreement with Biotechnology Developments for Industry in Pharmaceuticals, S.L.U.; and collaboration with Syngene International Limited. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej